Lymphoma Diagnosis and Staging
Diagnostic Approach
- Excisional lymph node biopsy is the gold standard for definitive diagnosis of suspected lymphoproliferative disorders, according to the European Society for Medical Oncology 1, 2
- Target the most accessible hypermetabolic lymph node, such as the right external iliac nodal conglomerate, for biopsy to yield diagnostic tissue 1
- Core needle biopsy is acceptable if surgical approach is impractical, but ensure adequate tissue for full immunohistochemical and molecular analysis, as recommended by the European Society for Medical Oncology 1, 3
- Fine-needle aspiration alone is inadequate and should not be used as the sole diagnostic method, as stated by the European Society for Medical Oncology 1
Essential Laboratory Tests
- Complete blood count with differential, peripheral blood smear review, comprehensive metabolic panel, lactate dehydrogenase, serum protein electrophoresis, and immunofixation are essential laboratory tests before biopsy, according to the National Comprehensive Cancer Network 4
- HIV, hepatitis B, and hepatitis C screening are also necessary, as recommended by the European Society for Medical Oncology 1, 2
- Beta-2 microglobulin is used for prognostic assessment, as stated by the European Society for Medical Oncology 2, 3
Pathology Requirements
- Morphological diagnosis with WHO classification, immunophenotyping panel, flow cytometry, and assessment of MYC and BCL2 rearrangement are mandatory for tissue analysis, according to the European Society for Medical Oncology 1, 3
- B-cell monoclonality testing by PCR-based method may be necessary if diagnostic doubt exists, as recommended by the European Society for Medical Oncology 1
Staging Completion
- PET/CT scan is the gold standard for staging and shows widespread lymphadenopathy suggesting stage III-IV disease, according to the European Society for Medical Oncology 1, 2, 5
- Bone marrow biopsy is not required since PET/CT already demonstrates advanced-stage disease, as stated by the European Society for Medical Oncology 1, 2
- Diagnostic lumbar puncture should be considered if high-risk features for CNS involvement are present after tissue diagnosis confirms lymphoma type, according to the European Society for Medical Oncology 1
Risk Stratification
- International Prognostic Index (IPI) and age-adjusted IPI (aa-IPI) are used for risk stratification if diffuse large B-cell lymphoma is confirmed, as recommended by the European Society for Medical Oncology 1, 2
- FLIPI is used for follicular lymphoma, according to the European Society for Medical Oncology 3
- Ann Arbor staging classification is used for staging, as stated by the European Society for Medical Oncology 2, 3
Special Considerations
- Clinical observation is appropriate for subcentimeter pulmonary nodules with mild uptake, according to the American College of Chest Physicians 6
- Biopsy of such nodules is not indicated unless they grow or show increasing metabolic activity on follow-up imaging, as recommended by the American College of Chest Physicians 6
- Focus should remain on accessible lymph nodes with higher SUV values for tissue diagnosis, according to the European Society for Medical Oncology 6, 7